Back to search results

A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis

Abroad (travel likely)RecruitingPHASE1

Conditions

Rheumatoid Arthritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Nizams Institute Of Medical Sciences, Hyderabad, Andhra Pradesh, India

    Contact: Study coordinator (Liza Rajasekhar) · 9391008618

  • Apollo Hospitals Ahmedabad, Ahmedabad, Gujarat, India

    Contact: Study coordinator (Vishnu Sharma) · 9978467914

  • Local Institution - 0003, Bangalore, Karnataka, India

  • Local Institution - 0009, Mysuru, Karnataka, India

  • All India Institute of Medical Sciences (AIIMS) - Nagpur, Nagpur, Maharashtra, India

    Contact: Study coordinator (Rajashree Khot) · 9823134598

  • Life Point Mutispecialty Hospital Pvt. Ltd., Pune, Maharashtra, India

    Contact: Study coordinator (Pathak Ameya Ramchandra) · 02066 434366/434343

  • Kalinga Institute of Medical Sciences- Bhubaneswar, Bhubaneswar, Odisha, India

    Contact: Study coordinator (Debashis Maikap) · 9040145062

  • Local Institution - 0002, Hyderabad, Telangana, India

  • Krishna Institute of Medical Sciences Limited, Secunderabad, Telangana, India

    Contact: Study coordinator (Sarath Veeravalli) · 9866000685
Study leads

  • Bristol-Myers Squibb

    Study Director

    Bristol-Myers Squibb

View source on ClinicalTrials.gov(opens in a new tab)